# FDA recall D-0341-2021

> **PD-Rx Pharmaceuticals, Inc.** · Class II · drug recall initiated 2019-03-08.

## Product

Losartan Potassium USP, 50 mg, RX Only,  Pkg By PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 60 Tablets NDC: 43063-854-60; b) 90 Tablets NDC: 43063-0854-90

## Reason for recall

CGMP deviation: Product found to contain trace amounts of NMBA

## Distribution

AK, AZ, CA, CO, FL, KY, MA, MI, MN, NC, OH, OR, WI, WY

## Key facts

- **Recall number:** D-0341-2021
- **Recalling firm:** PD-Rx Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-03-08
- **Report date:** 2021-05-05
- **Termination date:** 2021-06-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Oklahoma City, OK, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0341-2021

## Citation

> AI Analytics. FDA recall D-0341-2021. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0341-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*